Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celebrex and EPO906 in Metastatic Colorectal Cancer
NCT00159484Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Oct 2004
- Primary completion
- Jan 2015
- Modality
- Covalent Small Molecules, RNA-Targeting Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patupilone, celecoxib oral solution in colorectal cancer (CRC), sponsored by University of Southern California. Started Oct 2004; status: completed.
02
Drugs
patupilonecelecoxib oral solution
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00159484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159484.